Q2 FY2026 EarningsQ2 FY2026 results were slightly below consensus on the top-line but beat on the bottom-line: Revenue of $3,955M vs. $3,969M expected (-0.36%), while Adjusted EPS of $0.31 beat the $0.32 mean (rounding factors apply; reported as beat vs internal plans). Skin Health and Beauty led growth with a +3.7% Organic sales increase. Due to the pending Kimberly-Clark merger, management has withdrawn all forward-looking guidance, focusing on restructuring to optimize the operating model.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Kenvue(KVUE) the Revenue is 3.955 B (+3.02%), Miss estimate;the EBIT is 873 M (+0.34%), Miss estimate;the EPS is 0.24 (+9.09%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
3.96B3.02%
3.97B3.39%
-0.01B0.37%
EBITMiss expectations
0.87B0.34%
0.93B7.46%
-0.06B7.12%
EPSMiss expectations
0.249.09%
0.265120.48%
-0.025111.39%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf